DiaMedica Therapeutics (DMAC)
(Real Time Quote from BATS)
$2.50 USD
+0.05 (2.04%)
Updated Apr 25, 2024 12:56 PM ET
2-Buy of 5 2
D Value D Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for DiaMedica Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -19.38 | -13.68 | -13.59 | -12.29 | -10.65 |
Depreciation/Amortization & Depletion | -1.19 | 0.01 | 0.19 | 0.02 | -0.05 |
Net Change from Assets/Liabilities | 0.09 | 0.59 | -0.46 | 1.20 | 0.39 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.75 | 1.57 | 1.62 | 1.90 | 1.21 |
Net Cash From Operating Activities | -18.73 | -11.51 | -12.25 | -9.19 | -9.10 |
Property & Equipment | -0.02 | -0.08 | -0.02 | -0.03 | 0.01 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -18.28 | 11.62 | -20.52 | -16.10 | -3.92 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -18.30 | 11.54 | -20.54 | -16.13 | -3.91 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 36.85 | 0.00 | 30.09 | 28.85 | 0.08 |
Issuance (Repayment) of Debt | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 36.84 | -0.01 | 30.09 | 28.85 | 0.07 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -0.19 | 0.02 | -2.70 | 3.53 | -12.94 |
Cash at Beginning of Period | 4.73 | 4.71 | 7.41 | 3.88 | 16.82 |
Cash at End of Period | 4.54 | 4.73 | 4.71 | 7.41 | 3.88 |
Diluted Net EPS | -0.60 | -0.52 | -0.65 | -0.78 | -0.89 |
Fiscal Year End for DiaMedica Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -19.38 | -14.22 | -9.75 | -5.27 |
Depreciation/Amortization & Depletion | NA | -1.19 | -0.83 | -0.42 | -0.20 |
Net Change from Assets/Liabilities | NA | 0.09 | -1.14 | -0.79 | -0.06 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 1.75 | 1.28 | 0.84 | 0.44 |
Net Cash From Operating Activities | NA | -18.73 | -14.92 | -10.12 | -5.09 |
Property & Equipment | NA | -0.02 | -0.02 | -0.01 | -0.01 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | -18.28 | -24.40 | -25.61 | 2.52 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -18.30 | -24.42 | -25.62 | 2.51 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 36.85 | 36.85 | 36.85 | 0.00 |
Issuance (Repayment) of Debt | NA | -0.01 | -0.01 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 36.84 | 36.84 | 36.85 | 0.00 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -0.19 | -2.50 | 1.11 | -2.58 |
Cash at Beginning of Period | NA | 4.73 | 4.73 | 4.73 | 4.73 |
Cash at End of Period | NA | 4.54 | 2.23 | 5.84 | 2.15 |
Diluted Net EPS | NA | -0.12 | -0.12 | -0.16 | -0.20 |